Company Filing History:
Years Active: 2014-2016
Title: The Innovations of Christophe Borg
Introduction
Christophe Borg is a notable inventor based in Pouilley les Vignes, France. He has made significant contributions to the field of biotechnology, particularly in the development of diagnostic tools and therapeutic proteins. With a total of 2 patents to his name, Borg's work has the potential to impact medical diagnostics and treatment.
Latest Patents
Borg's latest patents include the "Truncated CD20 protein, deltaCD20 - Diagnostic kit comprising an oligonucleotide probe for the mRNA encoding a polypeptide having an amino acid sequence substantially identical to that of SEQ ID NO: 2." This innovation aims to enhance diagnostic capabilities in identifying specific proteins. Another significant patent is the "Truncated CD20 protein, deltaCD20 - Isolated nucleic acid sequence encoding the CD20 gene comprising SEQ ID NO: 5, recombinant vector comprising a nucleic acid sequence placed under the control of one or a plurality of elements required for the expression thereof in a host cell, and method for improving the efficacy of a treatment comprising using a nucleic acid sequence comprising SEQ ID NO: 5." This patent focuses on improving treatment efficacy through genetic engineering.
Career Highlights
Throughout his career, Christophe Borg has worked with esteemed organizations such as the Etablissement Français Du Sang. His experience in these institutions has allowed him to collaborate on various projects aimed at advancing medical science.
Collaborations
Borg has collaborated with notable colleagues, including Christophe Ferrand and Marina Deschamps. These partnerships have contributed to the development of innovative solutions in the field of biotechnology.
Conclusion
Christophe Borg's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatment options.